Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells attack tumor and infected cells, but the receptors and ligands that stimulate them are poorly understood. Here we report the expression cloning of two murine ligands for the lectin-like receptor NKG2D. The two ligands, H-60 and Rae1 beta, are distant relatives of major histocompatibility complex class I molecules. NKG2D ligands are not expressed by most normal cells but are up-regulated on numerous tumor cells. We show that mouse NKG2D is expressed by NK cells, activated CD8+ T cells and activated macrophages. Expression of either NKG2D ligand by target cells triggers NK cell cytotoxicity and interferon-gamma secretion by NK cells, as well as nitric oxide release and tumor necrosis factor alpha transcription by macrophages. Thus, through their interaction with NKG2D, H-60 and Rae1 beta are newly identified potent stimulators of innate immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2000
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146 · cited 1×
“The extrachromosomal DNA was extracted from the sorted cells as describe”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“The recombinant protein was purified from inclusion bodies and refolded in vitro as describe”
MethodActivation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“The MHC-encoded proteins MICA and the closely related MICB are distantly related to MHC class I protein”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 2×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialAn Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039 · cited 1×
“Recent evidence indicates that human NKG2D forms a homodimer that associates with the signaling subunit DAP10 on the surface of NK cells and CD8 + T cell”
BackgroundBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017 · cited 1×
“MICA and MICB are normally expressed on a subset of intestinal epithelial cells, but their expression is up-regulated by cellular stres”
Background
Research works printed but not linked: 2
- Cosman, D. et al. The human cytomegalovirus (HCMV) glycoprotein, UL16, binds to the MHC class I-related protein, MICB/PERB11, and to two novel, MHC class I-related molecules, ULBP1 and ULBP2. FASEB J. 14, A1018 (2000).
- Chalupny, J. et al. Soluble forms of the novel MHC class I–related molecules, ULBP1 and ULBP2, bind to, and functionally activate NK cells. FASEB J. 14, A1018 (2000).
Cited by
Items 101–200 of 875
TLR-dependent cross talk between human Kupffer cells and NK cells
Tu, Z., Bozorgzadeh, A., Pierce, R. H., Kurtis, J., Crispe, I. N., & Orloff, M. S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072195 · Cited by 228
Coudert, J. D., Zimmer, J., Tomasello, E., Cebecauer, M., Colonna, M., Vivier, E., & Held, W. (2005) · Blood · doi:10.1182/blood-2005-03-0918 · Cited by 226
Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells
Rabinovich, B. A., Li, J., Shannon, J., Hurren, R., Chalupny, J., Cosman, D., & Miller, R. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3572 · Cited by 223
“It is highly promiscuous, and its ligands include a variety of distantly related MHC-I homologues that are often up-regulated on stressed and activated cells (12, 13).”
BackgroundInfluentialA novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development
Eckelhart, E., Warsch, W., Zebedin, E., Simma, O., Stoiber, D., Kolbe, T., Rülicke, T., Mueller, M., Casanova, E., & Sexl, V. (2011) · Blood · doi:10.1182/blood-2010-06-291633 · Cited by 222
MIC Genes: From Genetics to Biology
Bahram, S. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)76018-x · Cited by 219
NKG2D ligands as therapeutic targets.
(2013) · Europe PMC (PubMed Central) · Cited by 218
Identification of the earliest natural killer cell–committed progenitor in murine bone marrow
Fathman, J. W., Bhattacharya, D., Inlay, M. A., Seita, J., Karsunky, H., & Weissman, I. L. (2011) · Blood · doi:10.1182/blood-2011-04-348912 · Cited by 213
Molecular mechanisms of natural killer cell activation in response to cellular stress
Chan, C. J., Smyth, M. J., & Martinet, L. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.26 · Cited by 213
Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors
Carlyle, J. R., Jamieson, A. M., Gasser, S., Clingan, C. S., Arase, H., & Raulet, D. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308304101 · Cited by 211
Self-citationBoles, K. S., Barchet, W., Diacovo, T., Cella, M., & Colonna, M. (2005) · Blood · doi:10.1182/blood-2005-02-0817 · Cited by 208
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo
Krmpotić, A., Busch, D. H., Bubić, I., Gebhardt, F., Hengel, H., Hasan, M., Scalzo, A. A., Koszinowski, U. H., & Jonjić, S. (2002) · Nature Immunology · doi:10.1038/ni799 · Cited by 208
Lee, K.-M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M., & Kumar, V. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031989 · Cited by 208
“In the case of P815 and RMA-S, the activating receptor is unknown, but is likely not NKG2D (46).”
BackgroundDelale, T., Paquin, A., Asselin-Paturel, C., Dalod, M., Brizard, G., Bates, E. E. M., Kastner, P., Chan, S., Akira, S., Vicari, A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6723 · Cited by 206
“Because NKG2D ligands are expressed on YAC-1 but not on RMA-S cells (52), it is possible that NKG2D plays a major role in the killing of YAC-1 cells in vitro.”
BackgroundHow Do Natural Killer Cells Find Self to Achieve Tolerance?
Yokoyama, W. M., & Kim, S. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.006 · Cited by 206
Tricking the balance: NK cells in anti-cancer immunity
Pahl, J., & Cerwenka, A. (2017) · Immunobiology · doi:10.1016/j.imbio.2015.07.012 · Cited by 205
“Murine NKG2D binds to its murine ligands retinoic acid early inducible 1 (Rae1), ULBP-like transcript (MULT-1) and minor histocompatibility antigen H60 and signals through DAP10 and DAP12 (Cerwenka et al., 2000; Diefenbach et al., 2000; Ullrich et al., 2013).”
BackgroundCutting Edge: Toll-Like Receptor Signaling in Macrophages Induces Ligands for the NKG2D Receptor
Hamerman, J. A., Ogasawara, K., & Lanier, L. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2001 · Cited by 205
“As NKG2D is also expressed on mouse CD8 T cells and activated macrophages (12, 23), it is possible that the RAE-1 on macrophages signals to these cell types as well.”
BackgroundLymphocyte activation via NKG2D: towards a new paradigm in immune recognition?
Vivier, E., Tomasello, E., & Paul, P. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00337-0 · Cited by 204
ULBP4 is a novel ligand for human NKG2D
Jan Chalupny, N., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A., & Cosman, D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00714-9 · Cited by 202
Cis association of Ly49A with MHC class I restricts natural killer cell inhibition
Doucey, M.-A., Scarpellino, L., Zimmer, J., Guillaume, P., Luescher, I. F., Bron, C., & Held, W. (2004) · Nature Immunology · doi:10.1038/ni1043 · Cited by 200
McGilvray, R. W., Eagle, R. A., Watson, N. F. S., Al-Attar, A., Ball, G., Jafferji, I., Trowsdale, J., & Durrant, L. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0991 · Cited by 196
Nowbakht, P., Ionescu, M.-C. S., Rohner, A., Kalberer, C. P., Rossy, E., Mori, L., Cosman, D., De Libero, G., & Wodnar-Filipowicz, A. (2005) · Blood · doi:10.1182/blood-2004-07-2585 · Cited by 196
Starting at the Beginning: New Perspectives on the Biology of Mucosal T Cells
Cheroutre, H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104522 · Cited by 196
Kim, J.-Y., Son, Y.-O., Park, S.-W., Bae, J.-H., Chung, J. S., Kim, H. H., Chung, B.-S., Kim, S.-H., & Kang, C.-D. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.56 · Cited by 195
“…NK cell activation via NKG2D receptor can occur despite the normal expression of MHC class I molecules on the target cells (Cerwenka et al., 2000; Diefenbach et al., 2000; O'Connor et al., 2006), stress-induced upregulation of NKG2D ligands in tumor cells may trigger an additional signal towards…”
BackgroundMICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Bühring, H. ‐., DICHGANS, J., Rammensee, H., Steinle, A., et al. (2003) · PubMed · Cited by 224
Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity
Klose, C. S. N., & Artis, D. (2020) · Cell Research · doi:10.1038/s41422-020-0323-8 · Cited by 190
Poggi, A., Venturino, C., Catellani, S., Clavio, M., Miglino, M., Gobbi, M., Steinle, A., Ghia, P., Stella, S., Caligaris-Cappio, F., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2417 · Cited by 188
“In mice, a family of proteins structurally related to ULBPs, the RAE-1 molecules, bind to NKG2D and induce cell activation (24, 37).”
BackgroundNKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases
Zompi, S., Hamerman, J. A., Ogasawara, K., Schweighoffer, E., Tybulewicz, V. L. J., Di Santo, J. P., Lanier, L. L., & Colucci, F. (2003) · Nature Immunology · doi:10.1038/ni930 · Cited by 189
Suppressing T cell motility induced by anti–CTLA-4 monotherapy improves antitumor effects
Ruocco, M. G., Pilones, K. A., Kawashima, N., Cammer, M., Huang, J., Babb, J. S., Liu, M., Formenti, S. C., Dustin, M. L., & Demaria, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61931 · Cited by 187
“RAE-1 is a member of a family of NKG2D ligands that are usually absent from normal cells but expressed on transformed, infected, or distressed cells (48) and are thought to play a pivotal role in helping the host discriminate “self” from “abnormal self” by stim-”
Variable receptors controlling activation and inhibition of NK cells
McQueen, K. L., & Parham, P. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00380-1 · Cited by 186
Body-barrier surveillance by epidermal γδ TCRs
Chodaczek, G., Papanna, V., Zal, M. A., & Zal, T. (2012) · Nature Immunology · doi:10.1038/ni.2240 · Cited by 185
Cancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy
Liu, Y., & Zeng, G. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182518e83 · Cited by 185
Hayakawa, Y., Kelly, J. M., Westwood, J. A., Darcy, P. K., Diefenbach, A., Raulet, D., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5377 · Cited by 185
“RMA and RMA-Rae-1 tumor cells were prepared as described elsewhere (20) and analyzed by flow cytometry using PE-labeled mNKG2D tetramer as described previously (10).”
BackgroundMethodSelf-citationCytotoxic CD4 T Cells in Antiviral Immunity
Marshall, N. B., & Swain, S. L. (2011) · BioMed Research International · doi:10.1155/2011/954602 · Cited by 184
“Engagement of NKG2D has been shown to activate the cytolytic activity of NK cells and gamma delta T cells [64–66].”
BackgroundTwo Human ULBP/RAET1 Molecules with Transmembrane Regions Are Ligands for NKG2D
Bacon, L., Eagle, R. A., Meyer, M., Easom, N., Young, N. T., & Trowsdale, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1078 · Cited by 184
“Truncated NKG2D ligands such as this may have a role in blocking receptor interactions, and their expression could be part of an immune evasion strategy used by tumors or infected cells (2, 6, 25).”
BackgroundActivation of natural killer cells by heat shock protein 70
Multhoff, G. (2009) · International Journal of Hyperthermia · doi:10.1080/02656730902902001 · Cited by 182
Chan, C. J., Andrews, D. M., McLaughlin, N. M., Yagita, H., Gilfillan, S., Colonna, M., & Smyth, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903225 · Cited by 180
“B16-Rae-1ε expresses the Rae-1ε ligand for NKG2D, whereas B16 and B16F10 do not (36).”
BackgroundWilcox, R. A., Tamada, K., Strome, S. E., & Chen, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4230 · Cited by 181
“NKG2D is a type II dimer with lectin-like domains capable of binding the HLA class Ib molecules MICA and MICB in the human, and H-60 and Rae1 in the mouse (15, 17–19).”
BackgroundThe DNA Damage Response Arouses the Immune System
Gasser, S., & Raulet, D. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4603 · Cited by 178
“mediated lysis in vitro , and dramatically reduces the tumorigenicity of tumor cell lines in vivo (3, 4, 9, 10).”
BackgroundSelf-citationContinuous engagement of a self-specific activation receptor induces NK cell tolerance
Tripathy, S. K., Keyel, P. A., Yang, L., Pingel, J. T., Cheng, T. P., Schneeberger, A., & Yokoyama, W. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072446 · Cited by 176
Role of T lymphocytes in tumor response to radiotherapy
Demaria, S., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00095 · Cited by 174
“We will review here the experimental evidence that anti-tumor T cells are key players in tumor control achieved by radiotherapy.”
BackgroundInterleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?
Vivier, E., Spits, H., & Cupedo, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2522 · Cited by 172
Expression of Stress-induced MHC Class I Related Chain Molecules on Human Melanoma
Vetter, C. S., Groh, V., Straten, P. T., Spies, T., Bröcker, E.-B., & Becker, J. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01700.x · Cited by 171
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity
Diefenbach, A., Hsia, J. K., Hsiung, M. B., & Raulet, D. H. (2003) · European Journal of Immunology · doi:10.1002/immu.200310012 · Cited by 170
Self-citationAllogeneic hematopoietic transplantation and natural killer cell recognition of missing self
Ruggeri, L., Aversa, F., Martelli, M. F., & Velardi, A. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00455.x · Cited by 172
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
Smyth, M. J., Swann, J., Kelly, J. M., Cretney, E., Yokoyama, W. M., Diefenbach, A., Sayers, T. J., & Hayakawa, Y. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041522 · Cited by 169
“Clearly, NKG2D ligand expression by tumor cells may not be a barrier to tumor growth since many primary tumors and tumor cell lines naturally express NKG2D ligands (17, 21, 25).”
BackgroundSelf-citationFunction of NKG2D in natural killer cell–mediated rejection of mouse bone marrow grafts
Ogasawara, K., Benjamin, J., Takaki, R., Phillips, J. H., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1236 · Cited by 169
Expression and function of NK cell receptors in CD8+ T cells
McMahon, C. W., & Raulet, D. H. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00242-9 · Cited by 169
Self-citationJinushi, M., Hodi, F. S., & Dranoff, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603503103 · Cited by 168
Evolution of effectors and receptors of innate immunity
Magor, B. G., & Magor, K. E. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00029-5 · Cited by 168
NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer
Cerwenka, A., & Lanier, L. L. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00070.x · Cited by 167
The Interplay Between Viral-Derived miRNAs and Host Immunity During Infection
Mishra, R., Kumar, A., Ingle, H., & Kumar, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03079 · Cited by 165
McMahon, C. W., Zajac, A. J., Jamieson, A. M., Corral, L., Hammer, G. E., Ahmed, R., & Raulet, D. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1444 · Cited by 162
“EL-4/Qa-1 stimulators were generated by subcloning Qa-1 cDNA into a MSCV-IRES-GFP retroviral vector, transducing the EL-4 lymphoma (H2, TIB-39; American Type Culture Collection) and using a cell sorter to isolate clones with high surface expression of Qa-1, using methods described previously (13).”
MethodSelf-citationPoggi, A., Prevosto, C., Massaro, A.-M., Negrini, S., Urbani, S., Pierri, I., Saccardi, R., Gobbi, M., & Zocchi, M. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6352 · Cited by 161
“However, we cannot exclude that up-regulation of MIC-A and/or ULBPs may occur in vivo as a consequence of stress signals, such as during chronic inflammation or viral infections (15–17).”
Regulation of ligands for the activating receptor NKG2D
Mistry, A. R., & O'Callaghan, C. A. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02652.x · Cited by 160
A Cluster of Ten Novel MHC Class I Related Genes on Human Chromosome 6q24.2–q25.3
Radosavljevic, M., Cuillerier, B., Wilson, M. J., Clément, O., Wicker, S., Gilfillan, S., Beck, S., Trowsdale, J., & Bahram, S. (2002) · Genomics · doi:10.1006/geno.2001.6673 · Cited by 160
Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists
Gorski, K. S., Waller, E. L., Bjornton-Severson, J., Hanten, J. A., Riter, C. L., Kieper, W. C., Gorden, K. B., Miller, J. S., Vasilakos, J. P., Tomai, M. A., et al. (2006) · International Immunology · doi:10.1093/intimm/dxl046 · Cited by 158
Bugide, S., Green, M. R., & Wajapeyee, N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802691115 · Cited by 155
“However, only a few studies have directly tested the effect of individual NKG2D ligands on NK cell-mediated cancer cell eradication (21, 26, 27).”
BackgroundDeguine, J., Bréart, B., Lemaître, F., Santo, J. P. D., & Bousso, P. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.016 · Cited by 179
Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
Hoeres, T., Smetak, M., Pretscher, D., & Wilhelm, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00800 · Cited by 154
Divergent and convergent evolution of NK-cell receptors
Barten, R., Torkar, M., Haude, A., Trowsdale, J., & Wilson, M. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01802-0 · Cited by 171
Epithelial barrier biology: good fences make good neighbours
Moens, E., & Veldhoen, M. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03506.x · Cited by 153
Mononuclear myeloid-derived “suppressor” cells express RAE-1 and activate natural killer cells
Nausch, N., Galani, I. E., Schlecker, E., & Cerwenka, A. (2008) · Blood · doi:10.1182/blood-2008-03-143776 · Cited by 151
Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
Awad, R. M., De Vlaeminck, Y., Maebe, J., Goyvaerts, C., & Breckpot, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01977 · Cited by 151
“Another way in which macrophages could contribute to the elimination of nascent cells is through release of nitric oxide (NO) and TNF-α, which in experimental settings can be induced through NK2GD triggering (27).”
BackgroundA Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease
Fang, M., Lanier, L. L., & Sigal, L. J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040030 · Cited by 151
“Identified cellular ligands for NKG2D in mice include H60, MULT1, and Rae-1 [45–49].”
BackgroundRadaev, S., Rostro, B., Brööks, A. G., Colonna, M., & Sun, P. D. (2001) · Immunity · doi:10.1016/s1074-7613(01)00241-2 · Cited by 164
Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege.
Ito, T., Ito, N., Saathoff, M., Stampachiacchiere, B., Bettermann, A., Bulfone-Paus, S., Takigawa, M., Nickoloff, B., & Paus, R. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23927.x · Cited by 146
Exosomes and the MICA-NKG2D system in cancer
Clayton, A., & Tabi, Z. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.03.003 · Cited by 149
Schnurr, M. M., Scholz, C., Rothenfußer, S., Galambos, P., Dauer, M., Röbe, J., Endres, S., & Eigler, A. (2002) · PubMed · Cited by 147
Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
Prajapati, K., Pérez, C., Plaza-Rojas, L., Burke, B., & Guevara-Patino, J. A. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.161 · Cited by 164
Chapter 2 Natural Killer Cell Tolerance
Jonsson, A. H., & Yokoyama, W. M. (2009) · Advances in immunology · doi:10.1016/s0065-2776(08)01002-x · Cited by 168
NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
Zhang, J., Basher, F., & Wu, J. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00097 · Cited by 146
A Structural Basis for the Association of DAP12 with Mouse, but Not Human, NKG2D
Rosen, D. B., Araki, M., Hamerman, J. A., Chen, T., Yamamura, T., & Lanier, L. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2470 · Cited by 146
The extended human leukocyte receptor complex: diverse ways of modulating immune responses
Barrow, A. D., & Trowsdale, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00653.x · Cited by 165
The immunogenomics of minor histocompatibility antigens
Roopenian, D. C., Choi, E. Y., & Brown, A. C. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.19007.x · Cited by 160
Lodoen, M. B., Abenes, G., Umamoto, S., Houchins, J. P., Liu, F.-Y., & Lanier, L. (2004) · Journal of Experimental Medicine · doi:10.1084/jem.20040583 · Cited by 168
“Ligands for murine NKG2D include retinoic early inducible-1 gene (RAE-1) , RAE-1 , RAE-1 , RAE-1 , and RAE-1 , H60 (9, 10), and MULT-1 (11).”
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
Badrinath, S., Dellacherie, M. O., Li, A. W., Zheng, S., Zhang, X., Sobral, M. C., Pyrdol, J. W., Smith, K. L., Lu, Y., Haag, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04772-4 · Cited by 156
The immune system of invertebrates and vertebrates
Pasquier, L. D. (2001) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s1096-4959(01)00306-2 · Cited by 165
Genetics of inflammatory bowel disease: The role of the HLA complex
Ahmad, T. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i23.3628 · Cited by 140
Elsner, L., Muppala, V., Gehrmann, M., Lozano, J., Malzahn, D., Bickeböller, H., Brunner, E., Zientkowska, M., Herrmann, T., Walter, L., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5523 · Cited by 140
Mesiano, G., Todorovic, M., Gammaitoni, L., Leuci, V., Giraudo, L., Carnevale‐Schianca, F., Fagioli, F., Piacibello, W., Aglietta, M., & Sangiolo, D. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.675323 · Cited by 139
“The main ligands recognized by NKG2D are MHC class I-related molecules A and B (MIC A/B) and members of the unique long 16-binding proteins (ULBPs), stress-inducible proteins expressed, almost exclusively, by malignant tumor cells regardless the original histotype [27,29-31].”
BackgroundCytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
Sangiolo, D. (2011) · Journal of Cancer · doi:10.7150/jca.2.363 · Cited by 138
“The main targets recognized by NKG2D are MIC A/B (MHC class I related molecules) and proteins of the ULBP family (ULBPs 1,2 and 3) [23-25] while the final killing is perforin and granzyme mediated.”
BackgroundActivation of natural killer cells by heat shock protein 70
Multhoff, G. (2002) · International Journal of Hyperthermia · doi:10.1080/0265673021000017109 · Cited by 138
An innately interesting decade of research in immunology
Germain, R. N. (2004) · Nature Medicine · doi:10.1038/nm1159 · Cited by 157
NKG2D signaling in cancer immunosurveillance
López‐Soto, A., Huergo-Zapico, L., Acebes‐Huerta, A., Villa-Álvarez, M., & Gonzalez, S. R. (2014) · International Journal of Cancer · doi:10.1002/ijc.28775 · Cited by 148
The role of the NKG2D receptor for tumor immunity
Coudert, J. D., & Held, W. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.008 · Cited by 150
“[58] Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH.”
InfluentialGlycolytic requirement for NK cell cytotoxicity and cytomegalovirus control
Mah-Som, A. Y., Rashidi, A., Keppel, M. P., Saucier, N., Moore, E. K., Alinger, J. B., Tripathy, S. K., Agarwal, S. K., Jeng, E. K., Wong, H. C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95128 · Cited by 152
Kunisawa, J., Takahashi, I., & Kiyono, H. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00475.x · Cited by 149
“Although mice do not have a functional MIC gene ortholog, they do have NKG2D receptors that recognize class-I-like molecules such as H60 (70) and members of the RAE class-I-like family (71).”
BackgroundThe DNA damage response, immunity and cancer
Gasser, S., & Raulet, D. H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.004 · Cited by 136
“In mice, ectopic expression of NKG2D ligands in rare cell lines that lack endogenous NKG2D ligands renders the cells sensitive to NK cell mediated attack in vitro and in vivo [9–11].”
BackgroundSelf-citationNKG2D ligands are expressed on stressed human airway epithelial cells
Borchers, M. T., Harris, N. L., Wesselkamper, S. C., Vitucci, M., & Cosman, D. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00327.2005 · Cited by 133
“The mouse Rae1 ligands are similarly expressed on tumor cell lines (1, 10), and Rae1 transcripts are increased in carcinogen-treated mouse skin and in the subsequent carcinomas (15).”
BackgroundSilencing Human NKG2D, DAP10, and DAP12 Reduces Cytotoxicity of Activated CD8+ T Cells and NK Cells
Karimi, M. A., Cao, T. M., Baker, J. B., Verneris, M. R., Soares, L. R. B., & Negrin, R. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7819 · Cited by 133
“This may be a reflection of conditions where selective NKG2D signaling is the predominant stimulus for activation, akin to enhancement of cytotoxicity by tumor cell lines transfected with NKG2D ligands that are otherwise resistant to NK cell killing (14, 20, 52).”
BackgroundGillard, G. O., Bivas-Benita, M., Hovav, A.-H., Grandpre, L. E., Panas, M. W., Seaman, M. S., Haynes, B. F., & Letvin, N. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002141 · Cited by 130
“The phenomenon of NK cell recognition and response to induced-self molecules has previously been implicated in both infections and oncogenesis[34,35,36,37], where ligands MULT1[38], H60[39], and Rae1[39,40]) for the activating receptor NKG2D are preferentially induced upon infection or cellular transformation[36,37,41…”
BackgroundNatural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases
Colucci, F., Schweighoffer, E., Tomasello, E., Turner, M., Ortaldo, J. R., Vivier, É., Tybulewicz, V. L. J., & Santo, J. P. D. (2002) · Nature Immunology · doi:10.1038/ni764 · Cited by 146
IL-21 Enhances Tumor Rejection through a NKG2D-Dependent Mechanism
Takaki, R., Hayakawa, Y., Nelson, A., Sivakumar, P. V., Hughes, S., Smyth, M. J., & Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2167 · Cited by 126
“In mice, NKG2D binds to several cell surface glycoproteins, including the retinoic acid early inducible-1 (RAE-1)(5) proteins (2, 3), a minor histocompatibility Ag H60 (2, 3), and murine UL-16-binding protein-like transcript-1 (4, 5).”
BackgroundMarkiewicz, M. A., Carayannopoulos, L. N., Naidenko, O. V., Matsui, K., Burack, R., Wise, E. L., Fremont, D. H., Allen, P. M., Yokoyama, W. M., Colonna, M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2825 · Cited by 126
“In both mice and humans, expression of NKG2D ligands by target cells potently induces NK cell cytotoxicity (3, 5, 9, 16, 17).”
BackgroundResultInfluentialInterrogating the repertoire: broadening the scope of peptide–MHC multimer analysis
Davis, M. M., Altman, J. D., & Newell, E. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3020 · Cited by 124
NKG2D in NK and T Cell-Mediated Immunity
Ogasawara, K., & Lanier, L. L. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-8786-4 · Cited by 138
“However, the NKG2D ligands are frequently expressed on a substantial number of human and mouse tumors, and, therefore, could potentially serve as “danger signals” to alert the immune system to the existence of these abnormal cells (22, 23, 31).”
Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn
Bloch‐Queyrat, C., Fondanèche, M., Chen, R., Yin, L., Relouzat, F., Veillette, A., Fischer, A., & Latour, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050449 · Cited by 124
“YAC-1 cells express high level of ligands for NKG2D, and YAC-1 cell lysis is mostly dependent on NKG2D receptor activation (4, 6).”
BackgroundJung, H., Hsiung, B., Pestal, K., Procyk, E., & Raulet, D. H. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120565 · Cited by 123
“In addition, cell types are likely to vary in the extent to which proliferation suffices to induce NKG2D ligands, as suggested by the fact that proliferating T cells in vitro expressed relatively small amounts of NKG2D ligands or none at all (Diefenbach et al., 2000; Cerboni et al., 2007).”
BackgroundSelf-citationNatural killer cells: integrating diversity with function
Cheent, K. S., & Khakoo, S. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03045.x · Cited by 130
Gleimer, M., & Parham, P. (2003) · Immunity · doi:10.1016/s1074-7613(03)00272-3 · Cited by 141
Metadata
- Authors
- Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature Immunology
- Published
- 2000-08
- Volume
- 1
- Issue
- 2
- Pages
- 119-126
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1603913234
- Cited by
- 878
- References
- 41
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 17 · 2020: 23 · 2019: 18 · 2018: 29 · 2017: 31 · 2016: 17 · 2015: 23 · 2014: 24 · 2013: 28 · 2012: 38
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NKG2D, NKG2D ligands, natural killer cells, macrophages, cancer cells, innate immunity, NK cell cytotoxicity, interferon-gamma, nitric oxide, TNF-α, MHC class I-related molecules, CD8+ T cells, expression cloning
- MeSH terms
- Animals, Chlorocebus aethiops, Cloning, Molecular, Cricetinae, Humans, Killer Cells, Natural, Ligands, Lymphocyte Activation, Macrophage Activation, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Immunologic, Tumor Cells, Cultured, Minor Histocompatibility Antigens, CHO Cells, Macrophages, Peritoneal, COS Cells, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.